Cargando…

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis

Detalles Bibliográficos
Autores principales:	Kalb, R, Ammann, J, Slowinski, T, Morgera, S, Kindgen-Milles, D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061758/ http://dx.doi.org/10.1186/cc9548

Ejemplares similares

Recurrent early filter clotting in regional citrate anticoagulated continuous venovenous hemodialysis due to undetected antibodies to heparin-platelet factor 4 complexes
por: Slowinski, T, et al.
Publicado: (2010)

Pilot study on a regional citrate anticoagulated continuous venovenous hemodiafiltration protocol with variable treatment dose
por: Slowinski, T, et al.
Publicado: (2010)

Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015)

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Super high-flux CVVHD using regional citrate anticoagulation: long-term stability of middle molecule clearance
por: Siebeck, M, et al.
Publicado: (2015)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Blood epuration of middle molecules in continuous venovenous hemodiafiltration with regional citrate anticoagulation versus systemic heparinization
por: Nogier, MB, et al.
Publicado: (2009)

Ionized calcium measurements during regional citrate anticoagulation in CRRT: we need better blood gas analyzers
por: Kindgen-Milles, Detlef, et al.
Publicado: (2015)

Citrate anticoagulation for continuous venovenous haemodiafiltration: the impact of a novel protocol on patients receiving therapy in one regional hospital
por: Highgate, J, et al.
Publicado: (2015)

Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
por: Schultheiß, Caroline, et al.
Publicado: (2012)

Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltration
por: Ooi, EL, et al.
Publicado: (2010)

Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
por: Morgera, S, et al.
Publicado: (2006)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Regional citrate anticoagulation (RCA) for continuous venovenous hemodiafiltration (CVVHDF): initial experience
por: Durão, M, et al.
Publicado: (2001)

Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis
por: Lenga, Ilan, et al.
Publicado: (2019)

Regional Anticoagulation with Citrate is Superior to Systemic Anticoagulation with Heparin in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
por: Park, Joon-Sung, et al.
Publicado: (2011)

Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial
por: Meersch, Melanie, et al.
Publicado: (2019)

Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation
por: dos Santos, Thais Oliveira Claizoni, et al.
Publicado: (2023)

Variable adsorption of insulin at catheter materials used in intensive care units: polyethylene vs polyurethane – possible cause for hypoglycemia during intensive insulin treatment?
por: Ley, S, et al.
Publicado: (2007)

Continuous venovenous haemofiltration in neonates
por: Mayell, S, et al.
Publicado: (2004)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

High-volume continuous venovenous hemofiltration reduces mortality in critically ill patients with acute renal failure
por: Van Ketel, R, et al.
Publicado: (2008)

Clearance of Sotalol on continuous venovenous haemofiltration
por: Roberts, H, et al.
Publicado: (2005)

Impact of continuous veno-venous hemodiafiltration with regional citrate anticoagulation on the acid-base balance of critically ill patients
por: Passos, RH, et al.
Publicado: (2006)

Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid
por: Morabito, S, et al.
Publicado: (2012)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin
por: Burford, E, et al.
Publicado: (2015)

Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs
por: Francey, T., et al.
Publicado: (2017)

Preventing continuous renal replacement therapies (CRRT)-induced hypophosphatemia using a phosphate-containing CRRT solution in the setting of regional citrate anticoagulation
por: Pistolesi, V, et al.
Publicado: (2014)

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Influence of continuous venovenous hemofiltration on transpulmonary thermodilution-derived parameters
por: Neirynck, V, et al.
Publicado: (2009)

Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study
por: Yu, Yan, et al.
Publicado: (2020)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Elimination of linezolid in patients undergoing low-flow continuous venovenous haemodiafiltration
por: Ide, T, et al.
Publicado: (2012)

Role of early continuous venovenous hemodiafiltration in septic shock and multiorgan failure
por: Soliman, M, et al.
Publicado: (2010)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Combined use of pumpless extracorporeal lung assist system and continuous renal replacement therapy with citrate anticoagulation in polytrauma patients
por: Atalan, HK, et al.
Publicado: (2013)

Effects of two different regional citrate anticoagulation CVVH protocols on acid-base status and phosphate supplementation
por: Morabito, S, et al.
Publicado: (2013)

Ceftriaxone pharmacokinetic properties during continuous venovenous haemofiltration using an in vitro model
por: Harvey, B, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_h0jhbad80sdns52upck1t4724m